Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Salido

Showing results (91-100 of 107) with videos related to

Pageof 11
Sort By:
Hemasphere|January 30, 2026
Unveiling relative lymphopenia and elevated monocyte-to-lymphocyte count as novel independent adverse prognostic factors in chronic myelomonocytic leukemia (CMML)-Proposal of the objective prognostic index for CMML (OPIC)Xavier Calvo, Abora Rial-Villavecchia, David Roman-Bravo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2015
Emergence of Multiple EGFR Extracellular Mutations during Cetuximab Treatment in Colorectal CancerSabrina Arena, Beatriz Bellosillo, Giulia Siravegna, et al.
Plos One|September 24, 2014
Accurate identification of ALK positive lung carcinoma patients: novel FDA-cleared automated fluorescence in situ hybridization scanning system and ultrasensitive immunohistochemistryEsther Conde, Ana Suárez-Gauthier, Amparo Benito, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2017
Defective Cyclin B1 Induction in Trastuzumab-emtansine (T-DM1) Acquired Resistance in HER2-positive Breast CancerMohammadA Sabbaghi, Gabriel Gil-Gómez, Cristina Guardia, et al.
The Journal of Molecular Diagnostics : JMD|February 1, 2026
Copy-Neutral Loss of Heterzygosity in Myelofibrosis: Parallel Evaluation with Optical Genome Mapping and Single-Nucleotide Polymorphism ArraysÁlvaro Díaz-González, Elvira Mora, Marta Garrote, et al.
Blood|May 19, 2010
Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma GroupMarta Salido, Cristina Baró, David Oscier, et al.
Genes, Chromosomes & Cancer|June 12, 2014
Interstitial 13q14 deletions detected in the karyotype and translocations with concomitant deletion at 13q14 in chronic lymphocytic leukemia: different genetic mechanisms but equivalent poorer clinical outcomeAnna Puiggros, Marta Venturas, Marta Salido, et al.
Cancers|August 12, 2022
<i>TP53</i> Abnormalities Are Underlying the Poor Outcome Associated with Chromothripsis in Chronic Lymphocytic Leukemia Patients with Complex KaryotypeSilvia Ramos-Campoy, Anna Puiggros, Joanna Kamaso, et al.
Nature Communications|May 23, 2022
p53 wild-type colorectal cancer cells that express a fetal gene signature are associated with metastasis and poor prognosisLaura Solé, Teresa Lobo-Jarne, Daniel Álvarez-Villanueva, et al.
The Journal of Investigative Dermatology|September 18, 2009
Oligonucleotide array-CGH identifies genomic subgroups and prognostic markers for tumor stage mycosis fungoidesRocío Salgado, Octavio Servitje, Fernando Gallardo, et al.
Pageof 11

Showing results (91-100 of 107) with videos related to

Sort By:
Pageof 11
Hemasphere|January 30, 2026
Unveiling relative lymphopenia and elevated monocyte-to-lymphocyte count as novel independent adverse prognostic factors in chronic myelomonocytic leukemia (CMML)-Proposal of the objective prognostic index for CMML (OPIC)Xavier Calvo, Abora Rial-Villavecchia, David Roman-Bravo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2015
Emergence of Multiple EGFR Extracellular Mutations during Cetuximab Treatment in Colorectal CancerSabrina Arena, Beatriz Bellosillo, Giulia Siravegna, et al.
Plos One|September 24, 2014
Accurate identification of ALK positive lung carcinoma patients: novel FDA-cleared automated fluorescence in situ hybridization scanning system and ultrasensitive immunohistochemistryEsther Conde, Ana Suárez-Gauthier, Amparo Benito, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2017
Defective Cyclin B1 Induction in Trastuzumab-emtansine (T-DM1) Acquired Resistance in HER2-positive Breast CancerMohammadA Sabbaghi, Gabriel Gil-Gómez, Cristina Guardia, et al.
The Journal of Molecular Diagnostics : JMD|February 1, 2026
Copy-Neutral Loss of Heterzygosity in Myelofibrosis: Parallel Evaluation with Optical Genome Mapping and Single-Nucleotide Polymorphism ArraysÁlvaro Díaz-González, Elvira Mora, Marta Garrote, et al.
Blood|May 19, 2010
Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma GroupMarta Salido, Cristina Baró, David Oscier, et al.
Genes, Chromosomes & Cancer|June 12, 2014
Interstitial 13q14 deletions detected in the karyotype and translocations with concomitant deletion at 13q14 in chronic lymphocytic leukemia: different genetic mechanisms but equivalent poorer clinical outcomeAnna Puiggros, Marta Venturas, Marta Salido, et al.
Cancers|August 12, 2022
<i>TP53</i> Abnormalities Are Underlying the Poor Outcome Associated with Chromothripsis in Chronic Lymphocytic Leukemia Patients with Complex KaryotypeSilvia Ramos-Campoy, Anna Puiggros, Joanna Kamaso, et al.
Nature Communications|May 23, 2022
p53 wild-type colorectal cancer cells that express a fetal gene signature are associated with metastasis and poor prognosisLaura Solé, Teresa Lobo-Jarne, Daniel Álvarez-Villanueva, et al.
The Journal of Investigative Dermatology|September 18, 2009
Oligonucleotide array-CGH identifies genomic subgroups and prognostic markers for tumor stage mycosis fungoidesRocío Salgado, Octavio Servitje, Fernando Gallardo, et al.
Pageof 11